Michael Mollerus
Advises U.S. and international corporate, real estate and private equity fund clients on the tax aspects of major transactions.
Michael advises U.S. and non-U.S. corporate, real estate and private equity fund clients on the tax aspects of initial public offerings, mergers, acquisitions, spinoffs and other major transactions, including structured financings. His clients have included many corporate and financial institutions including Bausch Health, Clarivate, Emerson, IHS Markit, Morgan Stanley, MSCI, Pfizer, Reckitt, Roche and Uniti Group.
Michael is consistently recognized for his work in the legal industry. A client notes in Chambers USA that, “He can talk in a way non-tax people can understand and has a good, easy approach to really complicated matters.”
He is an officer on the Corporate Tax Committee of the American Bar Association’s Section of Taxation. He is a member of the Executive Committee of the New York State Bar Association’s Taxation Section and serves as co-chair of the Section’s Corporations Committee.
Experience highlights
Mergers & Acquisitions
- JPMorgan in connection with multiple transactions, including its acquisition of First Republic
- Emerson in connection with numerous transactions, including its disposition of its Climate Technologies and Network Power businesses and its acquisition of National Instruments
- Morgan Stanley in connection with numerous matters, including its acquisitions of E*TRADE and Eaton Vance
- IHS Markit in connection with multiple transactions, including its acquisition by S&P Global
- Roche in connection with numerous acquisitions, including its acquisitions of Genentech and InterMune
- Clarivate in connection with numerous acquisitions, including its acquisitions of CPA Global and ProQuest
- Reckitt Benckiser in connection with multiple transactions, including its acquisition of Mead Johnson
- Gilead Sciences in connection with multiple acquisitions, including its acquisition of Immunomedics
Spinoffs
- Bausch Health in connection with its pending separation of Bausch + Lomb
- Pfizer in connection with its Reverse Morris Trust with Mylan
- Reckitt Benckiser in connection with the tax-free demerger of Indivior
- Morgan Stanley in connection with its spinoff of Discover
IPOs and Other Financings
- On in connection with its IPO
- Bausch + Lomb in connection with its IPO
- MSCI in connection with its IPO and various financings
- Kosmos Energy in connection with its IPO and various financings
- Cobalt International Energy in connection with its IPO and various financings
- Delphi Automotive in connection with its IPO and various financings
- Markit in connection with its IPO
Real Estate
- Uniti Group, a communications infrastructure REIT, in connection with numerous matters, including acquisitions, leasing transactions and debt and equity financings
- Prime Property Fund, a private institutional REIT advised by Morgan Stanley, in connection with numerous matters, including acquisitions and financings
Insights
News
Credentials
Recognition
Chambers USA – Tax, New York
Chambers Global – Tax: International Tax
Who’s Who Legal – Corporate Tax, Advisory
Who’s Who Legal – Corporate Tax, Controversy
Law360 – “Tax MVP of the Year,” 2014
Education
- magna cum laude
- Editor, Harvard Law Review
- magna cum laude
Clerkships
Professional history
- Partner, 1997-present
- Associate, 1990-1997
- Washington DC office, 1990-1992 and 1994-1995
- London office, 1992-1994
Qualifications and admissions
- State of New York